Ingevity Corporation last reported quarterly results on Nov 4, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $305.1 million (-8.4% year over year) and diluted EPS of $1.41. It usually reports 29–56 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 24, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Feb 25, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 29–56 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 4, 2026
35 days after quarter end
From press release
|
Q3 FY2026
ended Sep 30, 2026
|
305
-8.4%
|
49
+13.3%
|
1.41
+19.5%
|
|
Jul 29, 2026
29 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
314
-5.2%
|
35
+124.1%
|
1.00
+124.9%
|
|
May 6, 2026
36 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
258
+4.1%
|
60
+191.7%
|
1.66
+196.4%
|
|
Feb 25, 2026
56 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
255
-3.1%
|
-85
-609.6%
|
-2.37
-618.2%
|
|
Nov 5, 2025
36 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
333
-0.2%
|
44
+140.6%
|
1.18
+140.1%
|
|
Aug 4, 2025
35 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
332
-15.1%
|
-146
+48.4%
|
-4.02
+48.5%
|
|
May 5, 2025
35 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
248
-27.1%
|
20
+136.6%
|
0.56
+136.4%
|
|
Jan 16, 2025
16 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
263
+351.0%
|
17
+114.2%
|
0.46
+114.2%
|
Company profile
- Industry
- Chemicals & Allied Products (SIC 2800)
- Listed as
- NGVT (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- North Charleston, SC
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1653477
Other Chemicals & Allied Products companies
- Akzo Nobel NV AKZOY
- Solstice Advanced Materials Inc. SOLS
- Balchem Corp BCPC
- Perimeter Solutions, Inc. PRM
- Innospec Inc. IOSP
- Chemours Co CC
- OLIN Corp OLN
- Huntsman CORP HUN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.